Diskussionsleitung: D. Frank (Kiel), W.-K. Kim (Bad Nauheim)
(P525) | Long-term clinical and echocardiographic outcome after transcatheter aortic valve replacement with the mechanically-expanding Lotus valve | |
O. Dumpies, J. Kaur, G. Stachel, M. Kitamura, A. Allali, M. Landt, N. Majunke, J. Wilde, S. Desch, M. Sandri, P. Kiefer, H. Thiele, D. Holzhey, G. Richardt, M. Abdel-Wahab (Leipzig, Bad Segeberg) | ||
(P526) | Left ventricular reverse remodeling in classical LF-LG patients after transcatheter aortic valve replacement – insights from the RhineHeart TAVR Registry | |
N. Wilde, A. Sugiura, V. Mauri, K. Piayda, B. Al-Kassou, J. Shamekhi, O. Maier, M. Weber, S. Zimmer, T. Zeus, V. Tiyerili, M. Adam, V. Veulemans, M. Kelm, S. Baldus, G. Nickenig, A. Sedaghat (Bonn, Köln, Düsseldorf, Dortmund) | ||
(P527) | Impact of the left atrial function index (LAFI) on outcome in patients undergoing transcatheter aortic valve replacement | |
J. Shamekhi, T. Q. A. Nguyen, H. Sigel, O. Maier, K. Piayda, T. Zeus, B. Al-Kassou, M. Weber, S. Zimmer, A. Sugiura, N. Wilde, M. Kelm, G. Nickenig, V. Veulemans, A. Sedaghat (Bonn, Düsseldorf) | ||
(P528) | Prognostic impact of the Get-With-The-Guidelines Heart-Failure risk score (GWTG-HF) after transcatheter aortic valve replacement in patients with low-flow low-gradient aortic valve stenosis | |
C. Eckel, J. Blumenstein, O. Husser, C. Grothusen, H. Al-Terki, M. U. Becher, H. Möllmann, V. Tiyerili (Dortmund, München, Bonn) | ||
(P529) | Analysis of Long-Term Survival Following Transcatheter Aortic Valve Implantation from a Single High-Volume Center | |
S. Dietz, M.-I. Murray, R. De Rosa, A. M. Zeiher, M. Vasa-Nicotera (Frankfurt, Frankfurt am Main) | ||
(P530) | Alternative access in patients with prohibitive surgical risk in the era of transfemoral transcatheter aortic valve replacement | |
A. Zubarevich, M. Szczechowicz, R. Malik, R. A. Janosi, A. Lind, M. Thielmann, A. Ruhparwar, A. Weymann, D. Wendt (Essen) | ||
(P531) | Positioning of the Image Plane in Phase Contrast MRI impacts Aortic Stenosis Assessment | |
F. Troger, M. Reindl, I. Lechner, C. Tiller, M. Holzknecht, M. Pamminger, P. Poskaite, C. Kremser, S. J. Reinstadler, A. Bauer, B. Metzler, G. Klug, A. Mayr (Innsbruck, AT) | ||
(P532) | A novel approach to determine aortic valve area with phase contrast cardiovascular magnetic resonance imaging | |
F. Troger, I. Lechner, M. Reindl, C. Tiller, M. Holzknecht, M. Pamminger, C. Kremser, S. J. Reinstadler, A. Bauer, B. Metzler, A. Mayr, G. Klug (Innsbruck, AT) | ||
(P533) | Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR - a multicenter experience | |
B. Al-Kassou, K. Piayda, T. Zeus, A. Aksoy, J. Shamekhi, M. Weber, E. Grube, J.-M. Sinning, S. Zimmer, M. Kelm, V. Veulemans, G. Nickenig, A. Sedaghat (Bonn, Düsseldorf, Köln) | ||
(P534) | A simplified approach including conscious sedation for transcatheter aortic valve implantation (TAVI): a 4-year single center experience and outcome analysis | |
L. Baez, T. Kräplin, M. Diab, S. Möbius-Winkler, C. Schulze, M. Franz (Jena) |